Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
+3.55M
-
Total reported value, excl. options
-
$685M
-
Value change
-
+$90.6M
-
Number of buys
-
80
-
Number of sells
-
-25
-
Price
-
$26.15
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q1 2020
119 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
of 69.1M outstanding shares and own 37.9% of the company stock.
Largest 10 shareholders include SC US (TTGP), LTD. (3.09M shares), NORWEST VENTURE PARTNERS XI, LP (2.35M shares), NORWEST VENTURE PARTNERS XII, LP (2.35M shares), JANUS HENDERSON GROUP PLC (1.18M shares), ALLIANCEBERNSTEIN L.P. (1.16M shares), WELLS FARGO & COMPANY/MN (1.11M shares), FMR LLC (1.09M shares), BlackRock Inc. (1.08M shares), VICTORY CAPITAL MANAGEMENT INC (1.06M shares), and MARSHALL WACE, LLP (1.02M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.